2025 Conference programme
Discover the tracks of 2025 edition
Steered by a prestigious Committee, the MedFIT conference programme brings together bright minds to discuss the latest trends in MedTech, Diagnostics and Digital Health, to debate on innovation-driven topics, to foster learning and spark conversations that matter. International experts will address current industry issues related to collaboration, financing, and digital health.
KEYNOTE SESSION
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 9:15 AM
- 9:45 AM
A smarter, more personalised, more accessible, and altogether better medicine? AI has already proven its deep impact on industry. A new era of entrepreneurship has begun, granting empowered researchers and industry leaders a unique opportunity to make a tangible impact on health innovation.
- Werner Lanthaler, CEO, WLan Holding
PLENARY SESSION
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 10:00 AM
- 11:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
The rise of digital health solutions is shifting healthcare towards a more patient-driven model. From wearable devices to AI-powered diagnostics, individuals and healthcare professionals are gaining insightful information from real-time monitoring, leading to better health management. To what extent are B2C models becoming significant in the sector? How can they complement traditional pathways? What is needed to bring B2C solutions to market? What obstacles can be met before reaching success? What regulatory, economic, ethical and other challenges come with this shift towards B2C solutions?
- Lynn Coorevits, Digital Health Innovation Manager, imec
- Harry Van Goor, Professor of Surgical Education, Radboud University Medical Center
- Caroline Pilot, Head of clinical products, HealthHero
- Romane Doriry, Innovation & Strategic Partnerships specialist, Roche
- Jaume Puig Adamuz, CEO, BIEL GLASSES
TRACK 1 - Fostering collaborative practices
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:30 AM
- 12:30 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Spin-offs play a crucial role in translating academic research into real-world solutions, but their success in fulfilling their mission depends on more than just great science. This session will discuss the importance and scope of collaborative research agreements between academic players and their spin-offs. How can academic institutions and tech transfer offices provide the right support to ensure long-term growth? What are the common terms set for such collaborative research agreements and why? What common hurdles do spin-offs face, and how can they be addressed? What are the key ingredients to a synergetic relationship between academia and spin-off? How could incubation and funding models adapt to better serve emerging MedTech and digital health companies?
- Paul Borm, Co-Founder & CTO, Nano4Imaging
- Louie Scott, Commercialisation executive, Imperial College London
- Alessandro Mazzetti, Head of Innovation and Entrepreneurship, University of Basel
- Erick Pano, Co-Founder, Puray
- Maximilien Vermandel, CEO, Hemerion Therapeutics
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 5:15 PM
- 6:00 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Is securing a deal with an industrial player a must-have nowadays for seed to growth stage start-ups? What exactly are big players looking for? This session will explore how decision makers assess potential collaborations for licensing and acquisitions. What are the key factors that make a start-up eye-catching? What common pitfalls can lead to failed partnerships? How can young companies navigate the complexities of working with top industries in the sector?
- Thomas Kondrup Hardahl, Director, Group Development & Strategy, Coloplast
- Diana-Ioana Pop, Global Strategic Partnership Manager, Nobel Biocare
- Quentin Merceron, Digital Venture Architect, Hartmann
DAY 2 - Wednesday, December 3rd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 3:00 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Sustainability has become a priority across industries, the European legislation evolving to answer the matching stakes. For the MedTech sector, it means unique challenges in designing environmentally responsible medical devices. How can companies, regulators, and healthcare providers work together to integrate sustainability into product development? How can public institutions, such as funds, participate in the implementation of sustainability as a compulsory criterion for new technologies?
- Amanda Chancellor, Global Sustainability Senior Manager, ResMed
- Antonio D’Angelo, CEO, Medicud
- Julian Lotz, CEO, Biovox
- Tim Barrow-Williams, Associate Director of Engineering, PA Consulting
TRACK 2 - Pre-seed to Series B: On financing innovation
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 3:00 PM
- 3:45 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
The boundaries between MedTech, biotech, and digital health are becoming increasingly blurred, with more investors looking at interdisciplinary opportunities. Data also shows the undeniable popularity of investment in AI and digital health, while pure MedTech investors are becoming rare. Does it mean that start-ups need a biotech, digital health or artificial intelligence component to be investable nowadays? What types of convergence are investors eyeing? How are investors weighing the risks and analysing the potential for significant returns? Where does pure MedTech investment position itself?
- Duko Drijfhout, Associate Director, Erasmus MC
- Craig Cooper, Partner, Serpentine Ventures
- Julien Hédou, CEO, SurgeCare
DAY 2 - Wednesday, December 3rd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 9:15 AM
- 10:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
European MedTech funding rose in 2025 but concentrated in fewer, larger AI-led rounds. Early stages remain competitive as investors price in MDR timelines, AI-Act obligations, and payer-driven evidence. Given new shifts in the landscape, how did investors allocate capital in 2025? What trends did we see emerge, and how are they influencing expectations for 2026? This session will provide investors’ perspectives on what’s driving funding decisions up to Series B, which sectors are gaining traction, and how start-ups can position themselves for the coming year.
- Pauline de Breteuil, Partner, UI Investissement
- Eric Bernos, Investment Director, Captech
- Daniel Auriel, Fundraising Specialist, 28DIGITAL
- Ariane De Marcillac, Associate, Gilde Healthcare
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 10:15 AM
- 11:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Fundraising is a critical step in the growth of any emerging company, but the path to securing investment is rarely straightforward. CEOs will share their firsthand experiences of raising funds: what strategies proved effective, what challenges they encountered, what they would do differently. How did they engage with investors? What role did strategic partnerships play? And what key lessons can other entrepreneurs take away from their journeys?
- Charlotta Topelius, CEO, CurifyLabs
- Barry Mc Cann, CEO, Nua Surgical
- Sam Windsor, CEO, IgnotaLabs
TRACK 3 – Digital Health & Medicine innovation
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 2:45 PM
Session that comprises a series of illustrative stories or cases followed by Q&As from the moderator and the audience.
Despite the growing number of digital health solutions and the positive impact that is expected for healthcare in their implementation, clinical adoption remains a complex and often slow process. Relying on case studies, experts will discuss the key factors that influence whether a digital health product is embraced by healthcare professionals and institutions, as well as by patients. To what extent can successful examples provide a roadmap for others? What are the biggest barriers toward digitalisation and adoption that still need to be addressed?
- Thomas Karopka, Senior Project Manager, BioCon Valley
- Sukrti Nagpal, Deputy Chief Medical Officer, Doccla
- Liam Burns, CEO, Qaelon Medical
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 4:30 PM
- 5:00 PM
Session that comprises a series of illustrative stories or cases followed by Q&As from the moderator and the audience.
Navigating market access pathways can be just as critical as regulatory approval for digital health providers. Relying on case studies, we’ll explore the choice of the first non-domestic market for young companies. When reaching this key stage in development, is there a country in the EU that could guarantee a better launch? What aspects should be considered to ensure a digital health solution is financially viable within a healthcare system and well positioned in a target market? What tools and collaborations can start-ups leverage to maximise their chance of success?
- Thomas Juhl Olesen, CEO & Founder, VECTRIX Health
- Juan Sebastian Suarez Valencia, Co-Founder & COO, Health Force
- Pauline Cohen, European Project Manager, Health Data Hub
DAY 2 - Wednesday, December 3rd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:30 AM
- 12:30 PM
Session that comprises a series of illustrative stories or cases followed by Q&As from the moderator and the audience.
As AI-driven medical technologies are taking root in the healthcare landscape, regulatory frameworks evolve to keep pace. The EU AI Act introduced new requirements that will shape how AI-powered medical devices are developed, tested, and brought to market. This session will examine the impacts of this new implementation, as well as those we can foresee. How do regulatory bodies, medical devices manufacturers and suppliers face these significant challenges? How are they navigating compliance? How can different stakeholders participate in shaping discussions with regulatory bodies?
- Marco Caproni, Global Director Software Product Assessment, TÜV SÜD
- David Blanquez, CEO, MJN Neuroserveis
- Quentin Merceron, Digital Venture Architect, Hartmann
- Jessica Garestier, Counsel Life Sciences, Dentons
Relive the 2024 edition
MedFIT 2024, held on December 3-4 in Lille, brought together global experts to explore trends in MedTech, diagnostics, and digital health. Keynote sessions focused on investment strategies, data-driven medicine, and startup-corporate collaborations. Practical workshops provided insights into market access and regulatory challenges.
As a dynamic platform for fostering innovation and collaboration, MedFIT 2024 played a crucial role in shaping the future of the healthcare industry.
